Beam Therapeutics (BEAM) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to -$1.1 billion.
- Beam Therapeutics' Enterprise Value fell 1611.79% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 1611.79%. This contributed to the annual value of -$850.7 million for FY2024, which is 2850.18% up from last year.
- According to the latest figures from Q3 2025, Beam Therapeutics' Enterprise Value is -$1.1 billion, which was down 1611.79% from -$1.2 billion recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Enterprise Value ranged from a high of -$156.5 million in Q3 2022 and a low of -$1.2 billion during Q1 2025
- Its 5-year average for Enterprise Value is -$845.9 million, with a median of -$1.0 billion in 2024.
- As far as peak fluctuations go, Beam Therapeutics' Enterprise Value surged by 8323.23% in 2022, and later plummeted by 54880.87% in 2023.
- Over the past 5 years, Beam Therapeutics' Enterprise Value (Quarter) stood at -$560.0 million in 2021, then plummeted by 92.53% to -$1.1 billion in 2022, then decreased by 10.36% to -$1.2 billion in 2023, then increased by 28.5% to -$850.7 million in 2024, then fell by 26.36% to -$1.1 billion in 2025.
- Its Enterprise Value stands at -$1.1 billion for Q3 2025, versus -$1.2 billion for Q2 2025 and -$1.2 billion for Q1 2025.